Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon
Thumbnail

Cook Medical recalls 38,000 angiographic catheters

Cook Medical recalled more than 38,000 of its angiographic catheters in the U.S. after receiving reports that the catheter tip may split or separate from the catheter. Of the 26 reports, 14 resulted in adverse events.

Medtronic recalls EnVeo R loading systems

Medtronic recalled 6,912 units of the EnVeo R loading systems after receiving two reports of particulates in packaged kits and six reports of particulates in the loading bath during valve loading as of July 6.

Lower executive function is associated with stroke and CHD risk

Older adults without dementia who had lower executive function had a higher risk of coronary heart disease and stroke, according to an analysis of a prospective, randomized controlled trial.

FDA warns of serious adverse events with LVADs

The FDA warned of serious adverse events associated with certain left ventricular assist devices (LVADs), which are implanted in patients with advanced heart failure.

Social media sites growing in popularity for LVAD patients and caregivers

Since former Vice President Dick Cheney had a left ventricular assist device (LVAD) implanted in 2012, general interest in the devices have increased and social media sites have included more information on them.

Potential adverse events with new anticoagulants

Since 2010, at least 8,000 deaths have been linked to three of the new anticoagulants compared with 700 for warfarin, the Milwaukee Journal Sentinel and MedPage Today report. The publications noted that there were around three times as many prescriptions for warfarin compared with the new anticoagulants last year.

Abbott commits to mitral valve disease treatments with two transactions

With two transactions on July 30, Abbott strengthened its structural heart business and emphasized its focus on treatments for mitral valve disease.

Thumbnail

At 5 years, everolimus-eluting stent is superior to paclitaxel-eluting stent

After five years, patients undergoing PCI had better safety and efficacy outcomes if they received an everolimus-eluting stent (EES) compared with a paclitaxel-eluting stent (PES), according to a long-term analysis of a clinical trial. The results, which were published online in JACC: Cardiovascular Interventions on July 22, confirmed previous findings at one and two years follow-up.

Displaying 6721 - 6728 of 10742

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.